🔗 Permalink

Inventor profile of:

David J. King

City:

Encinitas, California

Country:

United States

Published Applications:

Last publication date:

2026-01-22

Top Assignees for applications by David J. King

The entities that hold a legal rights for patent applications filed by inventor King David J.:

ANAPTYSBIO, INC. 19 San Diego, CA United States
Tesaro, Inc. 2 Wilmington, DE United States
Lassen Therapeutics, Inc. 2 San Diego, CA United States
MOMENTA PHARMACEUTICALS, INC. 2 Cambridge, MA United States
Fred Hutchison Cancer Center 1 Seattle, WA United States
Momenta Pharmaceuticals, Inc. 1 Titusville, NJ United States
Lassen Therapeutics 1, Inc. 1 San Diego, CA United States
TESARO, Inc. 1 Waltham, MA United States

Recent patent applications by King David J.

David J. King from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-22

US20260022181A1

Chemistry; metallurgy

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

#2 | 2026-01-08

US20260008858A1

Chemistry; metallurgy

ANTI-INTERLEUKIN-11 RECEPTOR SUBUNIT ALPHA (IL-11RA) ANTIBODIES

#3 | 2025-12-04

US20250368746A1

Chemistry; metallurgy

METHOD OF TREATING DISEASES OR CONDITIONS BY ADMINISTERING AN ANTI-INTERLEUKIN-11 RECEPTOR SUBUNIT ALPHA (IL-11RA) ANTIBODY

#4 | 2025-12-04

US20250368745A1

Chemistry; metallurgy

ANTI-IL 18BP ANTIBODIES

#5 | 2025-12-04

US20250368739A1

Chemistry; metallurgy

Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3)

#6 | 2025-10-23

US20250326856A1

Chemistry; metallurgy

HUMANIZED ANTI-CD45 ANTIBODIES AND USES THEREOF

#7 | 2025-01-09

US20250011444A1

Chemistry; metallurgy

ANTI-INTERLEUKIN-11 RECEPTOR SUBUNIT ALPHA (IL-11RA) ANTIBODIES

#8 | 2024-12-26

US20240425606A1

Chemistry; metallurgy

ANTI-IL-11RA ANTIBODIES

#9 | 2024-12-19

US20240417479A1

Chemistry; metallurgy

ANTI-IL 18BP ANTIBODIES

#10 | 2024-09-05

US20240294631A1

Chemistry; metallurgy

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

#11 | 2024-06-20

US20240199753A1

Chemistry; metallurgy

Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies

#12 | 2024-05-16

US20240158508A1

Chemistry; metallurgy

FcRn Antibodies and Methods of Use Thereof

#13 | 2023-12-28

US20230416368A1

Chemistry; metallurgy

Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3)

#14 | 2023-10-19

US20230331843A1

Chemistry; metallurgy

Antibodies Directed Against Programmed Death-1(PD-1)

#15 | 2023-02-16

US20230049725A1

Chemistry; metallurgy

FcRn Antibodies and Methods of Use Thereof

#16 | 2022-11-17

US20220363759A1

Chemistry; metallurgy

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3 (TIM-3)

#17 | 2022-06-02

US20220169734A1

Chemistry; metallurgy

Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

#18 | 2022-03-24

US20220089739A1

Chemistry; metallurgy

Antibodies Directed Against Programmed Death-1 (PD-1)

#19 | 2021-12-16

US20210388095A1

Chemistry; metallurgy

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

#20 | 2021-08-05

US20210238275A1

Chemistry; metallurgy

FcRn antibodies and methods of use thereof

#21 | 2021-06-03

US20210163589A1

Chemistry; metallurgy

Antibodies Directed Against Programmed Death-1(PD-1)

#22 | 2021-04-01

US20210095026A1

Chemistry; metallurgy

Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)

#23 | 2021-02-11

US20210040198A1

Chemistry; metallurgy

Method of treating autoimmune disease with antibodies against IL-33

#24 | 2020-09-24

US20200299382A1

Chemistry; metallurgy

FcRn antibodies and methods of use thereof

#25 | 2020-05-14

US20200148770A1

Chemistry; metallurgy

Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3)

#26 | 2020-03-19

US20200087408A1

Chemistry; metallurgy

Method of treating pustular psoriasis with antibodies directed against interleukin 36 receptor (IL-36R)

#27 | 2019-09-19

US20190284280A1

Chemistry; metallurgy

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3 (TIM-3)

#28 | 2019-08-22

US20190256600A1

Chemistry; metallurgy

Antibodies directed against programmed death-1 (PD-1)

#29 | 2019-08-22

US20190256596A1

Chemistry; metallurgy

ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)

#30 | 2018-12-06

US20180346562A1

Chemistry; metallurgy

Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33)

#31 | 2018-05-10

US20180127500A1

Chemistry; metallurgy

Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

#32 | 2018-05-10

US20180127496A1

Chemistry; metallurgy

Antibodies directed against lymphocyte activation gene 3 (LAG-3)

#33 | 2018-04-05

US20180094065A1

Chemistry; metallurgy

Antibodies directed against interleukin 36 receptor (IL-36R)

#34 | 2018-02-22

US20180051082A1

Chemistry; metallurgy

Antibodies directed against programmed death-1 (PD-1)

#35 | 2018-01-18

US20180016334A1

Chemistry; metallurgy

FcRn antibodies and methods of use thereof

#36 | 2017-06-08

US20170158762A1

Chemistry; metallurgy

ANTIBODIES DIRECTED AGAINST DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1 (DDR1)

#37 | 2016-11-17

US20160333090A1

Chemistry; metallurgy

Antibodies directed against interleukin-33 (IL-33) and methods of making and using

#38 | 2016-03-17

US20160075783A1

Chemistry; metallurgy

Antibodies directed against programmed death-1 (PD-1)

#39 | 2015-04-30

US20150118226A1

Chemistry; metallurgy

Antibodies directed against nerve growth factor (NGF)

#40 | 2014-03-20

US20140079691A1

Chemistry; metallurgy

THERMOSTABLE ANTIBODY FRAMEWORK REGIONS

#41 | 2014-02-27

US20140056878A1

Chemistry; metallurgy

Humanized antibodies directed against complement protein C5

#42 | 2013-04-25

US20130102031A1

Chemistry; metallurgy

USE OF SOMATIC HYPERMUTATION TO CREATE INSERTION AND DELETION MUTATIONS IN VITRO

#43 | 2013-04-25

US20130101601A1

Chemistry; metallurgy

Antibodies directed against nerve growth factor (NGF)

InventorID:

209103 ⎘